Johnson & Johnson
JNJNYSE
Product information
What is Johnson & Johnson (JNJ)?
Johnson & Johnson is a US healthcare company based in New Brunswick, New Jersey, founded in 1886. Its shares trade on the NYSE under the ticker JNJ. In 2023 the company separated its consumer health business into a standalone company called Kenvue and has since focused on two main areas of activity.
The Innovative Medicine unit develops prescription drugs in areas such as oncology, immunology, neuroscience, cardiopulmonary diseases and infectious diseases; Darzalex and Tremfya are among the well-known products in this portfolio. The MedTech unit offers cardiovascular devices, surgical equipment, vision products and orthopedic products. The company has announced plans to separate its orthopedics business, DePuy Synthes.
Key themes when following JNJ stock include biosimilar competition for drugs whose patents expire, new drug approvals, growth in the medical device businesses, progress on the orthopedics separation and litigation related to talc powder. On Lzzo.com, the Johnson & Johnson share price in US dollars appears together with a historical chart and technical indicators.
Sources: jnj.com, investor.jnj.com
- Name
- Johnson & Johnson
- Symbol
- JNJ
- Market
- Stocks
What to look for in the technical analysis of Johnson & Johnson
Moving averages help assess the trend and RSI helps assess momentum. Indicators are calculated from real history; when there is not enough history or the required candle fields are missing, the indicator is not calculated. Past results do not guarantee future performance.
Technical indicators
Calculated from observed daily candles (at least 201 observations). No intraday indicators. Indicators are descriptive, not a buy/sell recommendation.
Investment Return CalculatorWith observed closes over the past year
Loading historical prices…